Despite a storied career in drug design that has spanned multiple decades, James Woody believes there is still a significant amount of work left to be accomplished with the development of tumor necrosis factor (TNF) inhibitor biologics. “I’m excited about developing novel therapies for patients and I’m also excited about just discovering things,” Woody said […]

Tonix Pharmaceuticals Holding jumped as much as 24% early Wednesday, the latest in a group of tiny health-care stocks to get a boost in volume, after day traders touted the company on message boards for no apparent reason. Trading in micro-cap companies that most Wall Street professionals ignore has made up roughly 20% of all […]

The investigational, potent, oral CDK9 inhibitor, zotiraciclib (ZTR/TG02) in combination with temozolomide (Temodar), demonstrated early improvement in progression-free survival (PFS) as treatment of patients with recurrent high-grade gliomas, meeting the primary end point of the phase 1B 17-C-0009 trial clinical trial (NCT02942264). Topline results announced in a press release by the developer of zotiraciclib, Adastra […]